Cyclic-di-GMP (disodium)


CAS No. : 2222132-40-1

(Synonyms: c-di-GMP (disodium); cyclic diguanylate (disodium); 5GP-5GP (disodium))

2222132-40-1
Price and Availability of CAS No. : 2222132-40-1
Size Price Stock
1mg $170 In-stock
5mg $450 In-stock
10mg $620 In-stock
50 mg Get quote
100 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-110382
M.Wt: 734.37
Formula: C20H22N10Na2O14P2
Purity: >98 %
Solubility: H2O : 160 mg/mL (ultrasonic)
Introduction of 2222132-40-1 :

Cyclic-di-GMP disodium is a STING agonist and a bacterial second messenger that coordinates different aspects of bacterial growth and behavior, including motility, virulence, biofilm formation, and cell cycle progression. Cyclic-di-GMP disodium has anti-cancer cell proliferation activity and also induces elevated CD4 receptor expression and cell cycle arrest. Cyclic-di-GMP disodium can be used in cancer research[1][2][3][4]. IC50 & Target:STING[1][2][3][4]. In Vitro:Cyclic-di-GMP disodium (0.5-50 μM; 5 days) inhibits proliferation of human colon cancer cells[1].
Cyclic-di-GMP disodium (0.5-50 μM; 5 days) specifically elevates CD4 expression in Jurkat cells[2].
Cyclic-di-GMP disodium (0.5-50 μM; 5 days) induces cell cycle arrest at the S-phase in Jurkat cells[2]. In Vivo:Cyclic-di-GMP disodium (100 μg/per; i.v.; two sequential vaccinations 9 days apart) enhances TriVax-induced immune responses to melanoma in mice and further increased the anti-tumor effects of TriVax[3].

Your information is safe with us.